Teva Pharmaceutical Industries (TEVA) Change in Acquisitions & Divestments (2016 - 2024)
Historic Change in Acquisitions & Divestments for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Q4 2025 value amounting to $42.0 million.
- Teva Pharmaceutical Industries' Change in Acquisitions & Divestments changed N/A to $42.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $82.0 million, marking a year-over-year increase of 10500.0%. This contributed to the annual value of $42.0 million for FY2025, which is 500.0% up from last year.
- Teva Pharmaceutical Industries' Change in Acquisitions & Divestments amounted to $42.0 million in Q4 2025.
- In the past 5 years, Teva Pharmaceutical Industries' Change in Acquisitions & Divestments registered a high of $107.0 million during Q2 2021, and its lowest value of $1.0 million during Q3 2022.
- For the 4-year period, Teva Pharmaceutical Industries' Change in Acquisitions & Divestments averaged around $36.9 million, with its median value being $40.0 million (2024).
- As far as peak fluctuations go, Teva Pharmaceutical Industries' Change in Acquisitions & Divestments soared by 346666.67% in 2021, and later plummeted by 9719.63% in 2022.
- Teva Pharmaceutical Industries' Change in Acquisitions & Divestments (Quarter) stood at $19.0 million in 2021, then crashed by 94.74% to $1.0 million in 2022, then skyrocketed by 3900.0% to $40.0 million in 2024, then rose by 5.0% to $42.0 million in 2025.
- Its Change in Acquisitions & Divestments was $42.0 million in Q4 2025, compared to $40.0 million in Q3 2024 and $1.0 million in Q3 2022.